Fabrication and evaluation of Eudragit^® polymeric films for transdermal delivery of piroxicam

References

• Alsarra IA. 2009. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery. J Microencapsul. 26:272–278.
   PubMed Web of Science ®Google Scholar
• Ammar HO, Ghorab M, Mahmoud AA, Makram TS, Ghoneim AM. 2013. Rapid pain relief using transdermal film forming polymeric solution of ketorolac. Pharm Dev Technol. 18:1005–1016.
   PubMed Web of Science ®Google Scholar
• Avdeef A. 1993. pH-metric log P. II: Refinement of partition coefficients and ionization constants of multiprotic substances. J Pharm Sci. 82:183–190.
   PubMed Web of Science ®Google Scholar
• Barthel HR, Axford-Gatley RA. 2010. Topical nonsteroidal anti-inflammatory drugs for osteoarthritis. Postgrad Med. 122:98–106.
   PubMed Web of Science ®Google Scholar
• Beetge E, du Plessis J, Muller DG, Goosen C, van Rensburg FJ. 2000. The influence of the physicochemical characteristics and pharmacokinetic properties of selected NSAID’s on their transdermal absorption. Int J Pharm. 193:261–264.
   PubMed Web of Science ®Google Scholar
• Benzon H, Rathmell JP, Wu CL, Turk DC, Argoff CE, Nuyianes C. 2008. Raj’s practical management of pain. Philadelphia: Elsevier Health Sciences.
   Google Scholar
• Chandak AR, Prasad Verma PR. 2010. Eudragit-based transdermal delivery system of pentazocine: physico-chemical, in vitro and in vivo evaluations. Pharm Dev Technol. 15:296–304.
   PubMed Web of Science ®Google Scholar
• Chandrashekar NS, Shobha Rani RH. 2008. Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Indian J Pharm Sci. 70:94–96.
   PubMed Web of Science ®Google Scholar
• Chantasart D, Chootanasoontorn S, Suksiriworapong J, Li SK. 2015. Investigation of pH influence on skin permeation behavior of weak acids using nonsteroidal anti-inflammatory drugs. J Pharm Sci. 104:3459–3470.
   PubMed Web of Science ®Google Scholar
• Chantasart D, Pongjanyakul T, Higuchi WI, Li SK. 2009. Effects of oxygen-containing terpenes as skin permeation enhancers on the lipoidal pathways of human epidermal membrane. J Pharm Sci. 98:3617–3632.
   PubMed Web of Science ®Google Scholar
• Chaudhary H, Rohilla A, Rathee P, Kumar V. 2013. Optimization and formulation design of carbopol loaded Piroxicam gel using novel penetration enhancers. Int J Biol Macromol. 55:246–253.
   PubMed Web of Science ®Google Scholar
• Dhawan B, Aggarwal G, Harikumar SL. 2014. Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation. Int J Pharm Investig. 4:65–76.
   PubMedGoogle Scholar
• Elgindy N, Samy W. 2009. Evaluation of the mechanical properties and drug release of cross-linked Eudragit films containing metronidazole. Int J Pharm. 376:1–6.
   PubMed Web of Science ®Google Scholar
• Esposito E, Cervellati F, Menegatti E, Nastruzzi C, Cortesi R. 2002. Spray dried Eudragit microparticles as encapsulation devices for vitamin C. Int J Pharm. 242:329–334.
   PubMed Web of Science ®Google Scholar
• Felton LA, McGinity JW. 1997. Influence of plasticizers on the adhesive properties of an acrylic resin copolymer to hydrophilic and hydrophobic tablet compacts. Int J Pharm. 154:167–178.
   Web of Science ®Google Scholar
• Fok KH, George PJ, Vicary FR. 1985. Peptic ulcers induced by piroxicam. Br Med J (Clin Res Ed). 290:117.
   PubMedGoogle Scholar
• Goosen C, du Plessis J, Müller DG, Janse van Rensburg LF. 1998. Correlation between physicochemical characteristics, pharmacokinetic properties and transdermal absorption of NSAID’s. Int J Pharm. 163:203–209.
   Web of Science ®Google Scholar
• Ita KB. 2014. Transdermal drug delivery: progress and challenges. J Drug Deliv Sci Technol. 24:245–250.
   Web of Science ®Google Scholar
• Jackson JK, Skinner KC, Burgess L, Sun T, Hunter WL, Burt HM. 2002. Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm Res. 19:411–417.
   PubMed Web of Science ®Google Scholar
• Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. 2006. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 332:1302–1308.
   PubMed Web of Science ®Google Scholar
• Kristmundsdottir T, Gudmundsson OS, Ingvarsdottir K. 1996. Release of diltiazem from Eudragit microparticles prepared by spray-drying. Int J Pharm. 137:159–165.
   Web of Science ®Google Scholar
• McCarberg BH, Argoff CE. 2010. Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. Int J Clin Pract. 64:1546–1553.
   PubMed Web of Science ®Google Scholar
• Mihalić M, Hofman H, Kuftinec J, Krile B, Čaplar V, Kajfež F, Blažević N. 1986. Piroxicam. In: Klaus F, editor. Analytical profiles of drug substances. New York: Academic Press. p. 509–531.
   Google Scholar
• Moffat AC, Osselton MD, Widdop B, Clarke EGC, editors. 2004. Clarke’s analysis of drugs and poisons: pharmaceuticals, body fluids and postmortem material. London: Pharmaceutical Press.
   Google Scholar
• Murthy SN, Zhao YL, Sen A, Hui SW. 2004. Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation. J Control Release. 99:393–402.
   PubMed Web of Science ®Google Scholar
• Naik A, Kalia YN, Guy RH. 2000. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol Today. 3:318–326.
   PubMedGoogle Scholar
• Namdeo RJVLG, Karthik JN, Hanmantrao MK. 2009. Glass transition temperature: Basics and application in pharmaceutical sector. Asian J Pharm. 3:82–89.
   Google Scholar
• Oth MP, Moës AJ. 1989. Sustained release solid dispersions of indomethacin with Eudragit RS and RL. Int J Pharm. 55:157–164.
   Web of Science ®Google Scholar
• Parashar P, Ramrakhiani M, Datt SC. 1999. Mechanical strength of blends of Eudragit RL 100 and poly(methyl methacrylate). Polymer Testing. 18:495–500.
   Web of Science ®Google Scholar
• Park E-S, Cui Y, Yun B-J, Ko I-J, Chi S-C. 2005. Transdermal delivery of piroxicam using microemulsions. Arch Pharm Res. 28:243–248.
   PubMed Web of Science ®Google Scholar
• Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. 2010. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 1:109–131.
   PubMedGoogle Scholar
• Prausnitz MR, Langer R. 2008. Transdermal drug delivery. Nat Biotechnol. 26:1261–1268.
   PubMed Web of Science ®Google Scholar
• Scarpignato C. 2013. Piroxicam-β-cyclodextrin: a GI safer piroxicam. Curr Med Chem. 20:2415–2437.
   PubMed Web of Science ®Google Scholar
• Siepmann F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. 2008. Polymer blends for controlled release coatings. J Control Release. 125:1–15.
   PubMed Web of Science ®Google Scholar
• Singh P, Roberts MS. 1994. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther. 268:144–151.
   PubMed Web of Science ®Google Scholar
• Skoug JW, Mikelsons MV, Vigneron CN, Stemm NL. 1993. Qualitative evaluation of the mechanism of release of matrix sustained release dosage forms by measurement of polymer release. J Control Release. 27:227–245.
   Web of Science ®Google Scholar
• Subedi R, Oh S, Chun M-K, Choi H-K. 2010. Recent advances in transdermal drug delivery. Arch Pharm Res. 33:339–351.
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopeial Convention. 2014. USP 38 – NF 33 The United States Pharmacopeia and National Formulary. Main edition plus supplements 1 and 2. Deutscher Apotheker Verlag.
   Google Scholar
• Vijaya R, Ruckmani K. 2011. In vitro and in vivo characterization of the transdermal delivery of sertraline hydrochloride Films. Daru. 19:424–432.
   PubMed Web of Science ®Google Scholar
• Vrečer F, Vrbinc M, Meden A. 2003. Characterization of piroxicam crystal modifications. Int J Pharm. 256:3–15.
   PubMed Web of Science ®Google Scholar
• Wathoni NPJS, Drijanto S. 2012. Effect of iontophoresis and penetration enhancers on the in vitro diffusion of a piroxicam gel. Int J Pharm Pharm Sci. 4:215.
   Google Scholar